EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

NAA10 (N-Alpha-Acetyltransferase 10): A Multifunctional Regulator in Development, Disease, and Cancer

Zeng Quan Yang, Ion John Campeanu, Ivan Lopez, Manaal Syed, Yuanyuan Jiang, Hilda Afisllari iD

Cells · 2025

DOI: 10.3390/cells14120863 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2025. Verfasst von Zeng Quan Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Detroit, MI 48201, USA. Hauptthemen laut MEDLINE: N-Terminal Acetyltransferase E, N-Terminal Acetyltransferase A, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Defense (DoD) Breast Cancer Program, DoD Peer Reviewed Cancer Research Program, DMC Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

NAA10 (N-alpha-acetyltransferase 10) is a pivotal enzyme in eukaryotic cells, serving as the catalytic subunit of the NatA complex, which is responsible for the N-terminal acetylation of approximately 40–50% of the human proteome. Beyond its canonical role in co-translational N-terminal acetylation, NAA10 also acetylates internal lysine residues of various proteins and exerts non-catalytic regulatory functions through diverse protein–protein interactions. Pathogenic variants in NAA10 are linked to a spectrum of developmental disorders, most notably Ogden syndrome, which is characterized by neurodevelopmental delay, cardiac defects, and craniofacial anomalies. In cancer, NAA10 is frequently overexpressed or genomically amplified, where its dysregulation correlates with tumor aggressiveness and poor prognosis. Functional studies implicate NAA10 in regulating cell cycle progression, apoptosis, migration, and other hallmarks of cancer. In this review, we summarize the structure, molecular mechanisms, and physiological functions of NAA10, as well as its roles in human diseases and cancer. We present in silico pan-cancer analyses that highlight its clinical significance and potential downstream pathways. Furthermore, we discuss the therapeutic potential and challenges of targeting NAA10 in cancer, and propose future research directions to better understand its multifaceted roles in health and disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

N-Terminal Acetyltransferase EN-Terminal Acetyltransferase ANeoplasmsHumansAnimals

Stichwörter der Autor:innen

N-terminal acetylationNAA10acetyltransferasecancerdevelopmental disorder

Substanzen

N-Terminal Acetyltransferase EN-Terminal Acetyltransferase ANAA10 protein, human

Autor:innen und Institutionen

  • Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Detroit, MI 48201, USA.
  • Department of Oncology, Wayne State University School of Medicine, Detroit, MI 48201, USA.

ORCID-Profile: Hilda Afisllari

Förderung

  • Department of Defense (DoD) Breast Cancer Program
  • DoD Peer Reviewed Cancer Research Program
  • DMC Foundation
  • Molecular Therapeutics Program of Karmanos Cancer Institute

Zitieren

APA

Yang, Z. Q., Campeanu, I. J., Lopez, I., Syed, M., Jiang, Y., & Afisllari, H. (2025). NAA10 (N-Alpha-Acetyltransferase 10): A Multifunctional Regulator in Development, Disease, and Cancer. Cells. https://doi.org/10.3390/cells14120863

Vancouver

Yang ZQ, Campeanu IJ, Lopez I, Syed M, Jiang Y, Afisllari H. NAA10 (N-Alpha-Acetyltransferase 10): A Multifunctional Regulator in Development, Disease, and Cancer. Cells. 2025. doi:10.3390/cells14120863

BibTeX
@article{Yang2025,
  author = {Yang, Zeng Quan and Campeanu, Ion John and Lopez, Ivan and Syed, Manaal and Jiang, Yuanyuan and Afisllari, Hilda},
  title = {NAA10 (N-Alpha-Acetyltransferase 10): A Multifunctional Regulator in Development, Disease, and Cancer},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14120863}
}
Kostenlos starten →